Latest Bristol-Myers Squibb Stories
SAN DIEGO and TAIZHOU CITY, China, April 29, 2014 /PRNewswire/ -- Ambrx Inc. and Zhejiang Hisun Pharmaceutical Company Ltd.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 24, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
Three new studies presented today at the International Liver CongressTM 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB).
SAN DIEGO, April 7, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, March 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Innovative Physician Executive Brings Breadth of Healthcare Experience LOS ANGELES, March 31, 2014 /PRNewswire/ -- Health economics and policy authority Precision Health Economics
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/cw7xqm/investigation) has announced the addition of the
LONDON, March 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.